How to Buy Shree Ganesh Remedies Ltd Shares?
You can easily buy the stocks/shares of Shree Ganesh Remedies Ltd (SGRL) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Shree Ganesh Remedies Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of SGRL as on 15th May 2025 is ₹732.50What is the return on Shree Ganesh Remedies Ltd share?
The past returns of Shree Ganesh Remedies Ltd (SGRL) share are- Past 1 week: N/A
- Past 1 month: -78.41
- Past 3 months: -6.32
- Past 6 months: -17.60
- Past 1 year: -28.53
- Past 3 years: 145.66
- Past 5 years: 846.92
What is the Dividend yield % on Shree Ganesh Remedies Ltd share?
The current dividend yield of Shree Ganesh Remedies Ltd (SGRL) is N/AWhat is the Market Cap of Shree Ganesh Remedies Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shree Ganesh Remedies Ltd (SGRL) is ₹789.11Cr as of 15th May 2025What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?
The 52-week high and low of Shree Ganesh Remedies Ltd (SGRL) is ₹950.05 and ₹600.What is the PE and PB ratio of Shree Ganesh Remedies Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Shree Ganesh Remedies Ltd are 34.21 and 6.46 respectively.Which sector does Shree Ganesh Remedies Ltd belong to?
Shree Ganesh Remedies Ltd (SGRL) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Shree Ganesh Remedies Ltd?
The peers or stocks similar to Shree Ganesh Remedies Ltd are: and many others.Can't decide whether or not to buy Shree Ganesh Remedies Ltd?
Worry no more! Login to Tickertape and check out Shree Ganesh Remedies Ltd (SGRL) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?
The 52-week high and low of Shree Ganesh Remedies Ltd (SGRL) is ₹950.05 and ₹600.1. Test Stocks FAQ for Shree Ganesh Remedies Ltd Shares?
You can easily buy the stocks/shares of Shree Ganesh Remedies Ltd (SGRL) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Shree Ganesh Remedies Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of SGRL as on 15th May 2025 is ₹732.50
Shree Ganesh Remedies Ltd
SGRL Share Price
732.500.79% (-5.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SGRL Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SGRL Performance & Key Metrics
SGRL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.22 | 6.46 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
SGRL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SGRL Company Profile
Shree Ganesh Remedies Limited is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions etc.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.55%
2.55%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
—
—
SGRL Sentiment Analysis
SGRL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
SGRL Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
SGRL Stock Growth Drivers
SGRL Stock Growth Drivers
5Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
SGRL Stock Challenges
SGRL Stock Challenges
2Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
SGRL Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
SGRL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SGRL
SGRL
Income
Balance Sheet
Cash Flow
Annual Normal View
SGRL Income Statement
SGRL Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 128.97 | 112.33 | 112.32 | |||
Raw Materials | 63.36 | 69.38 | 69.38 | |||
| Power & Fuel Cost | 6.39 | |||||
| Employee Cost | 8.41 | |||||
| Selling & Administrative Expenses | 9.42 | |||||
| Operating & Other expenses | -3.49 | |||||
EBITDA | 44.88 | 42.95 | 42.94 | |||
| Depreciation/Amortization | 6.11 | 9.57 | 9.56 | |||
| PBIT | 38.77 | 33.38 | 33.38 | |||
| Interest & Other Items | 0.61 | 2.11 | 2.12 | |||
| PBT | 38.16 | 31.27 | 31.26 | |||
| Taxes & Other Items | 10.05 | 8.20 | 8.20 | |||
| Net Income | 28.11 | 23.07 | 23.06 | |||
| EPS | 21.88 | 17.96 | 17.95 | |||
| DPS | 0.50 | 0.00 | 0.00 | |||
| Payout ratio | 0.02 | 0.00 | 0.00 |
SGRL Company Updates
SGRL Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
SGRL Past Performance & Peer Comparison
SGRL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shree Ganesh Remedies Ltd | 34.21 | 6.46 | — |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
SGRL Stock Price Comparison
Compare SGRL with any stock or ETFCompare SGRL with any stock or ETF
SGRL
SGRL Holdings
SGRL Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
SGRL Promoter Holdings Trend
SGRL Promoter Holdings Trend
SGRL Institutional Holdings Trend
SGRL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SGRL Shareholding Pattern
SGRL Shareholding Pattern
SGRL Shareholding History
SGRL Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SGRL stock
smallcases containing SGRL stock
Looks like this stock is not in any smallcase yet.
SGRL Events
SGRL Events
SGRL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
SGRL Dividend Trend
No dividend trend available
SGRL Upcoming Dividends
SGRL Upcoming Dividends
No upcoming dividends are available
SGRL Past Dividends
SGRL Past Dividends
Cash Dividend
Ex DateEx DateSep 6, 2023
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 6, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Final
Final | Div/Share: ₹1.75
Dividend/Share
₹1.75
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 1, 2020
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 1, 2020
Cash Dividend
Ex DateEx DateAug 22, 2019
Final
Final | Div/Share: ₹1.25
Dividend/Share
₹1.25
Ex DateEx Date
Aug 22, 2019
SGRL Stock News & Opinions
SGRL Stock News & Opinions
Articles & Videos
Earnings
Shree Ganesh Remedies consolidated net profit declines 47.66% in the March 2025 quarter
Net profit of Shree Ganesh Remedies declined 47.66% to Rs 6.59 crore in the quarter ended March 2025 as against Rs 12.59 crore during the previous quarter ended March 2024. Sales declined 34.56% to Rs 24.43 crore in the quarter ended March 2025 as against Rs 37.33 crore during the previous quarter ended March 2024. For the full year,net profit declined 17.93% to Rs 23.07 crore in the year ended March 2025 as against Rs 28.11 crore during the previous year ended March 2024. Sales declined 13.74% to Rs 108.60 crore in the year ended March 2025 as against Rs 125.90 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales24.4337.33 -35 108.60125.90 -14 OPM %40.4045.38 -36.1033.21 - PBDT11.2018.11 -38 40.8344.27 -8 PBT8.7716.25 -46 31.2738.16 -18 NP6.5912.59 -48 23.0728.11 -18 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Shree Ganesh Remedies schedules board meeting
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Shree Ganesh Remedies to table results
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 5 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Shree Ganesh Remedies standalone net profit declines 1.98% in the September 2024 quarter
Net profit of Shree Ganesh Remedies declined 1.98% to Rs 6.42 crore in the quarter ended September 2024 as against Rs 6.55 crore during the previous quarter ended September 2023. Sales declined 3.26% to Rs 32.33 crore in the quarter ended September 2024 as against Rs 33.42 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.3333.42 -3 OPM %34.9827.59 - PBDT11.0710.01 11 PBT8.658.60 1 NP6.426.55 -2 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies to declare Quarterly Result
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies AGM scheduled
Shree Ganesh Remedies announced that the 29th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies announces board meeting date
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Shree Ganesh Remedies standalone net profit rises 2.42% in the June 2024 quarter
Net profit of Shree Ganesh Remedies rose 2.42% to Rs 4.65 crore in the quarter ended June 2024 as against Rs 4.54 crore during the previous quarter ended June 2023. Sales declined 7.26% to Rs 24.78 crore in the quarter ended June 2024 as against Rs 26.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7826.72 -7 OPM %32.8524.59 - PBDT8.367.29 15 PBT6.346.27 1 NP4.654.54 2 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Shree Ganesh Remedies announces board meeting date
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 2.30%
Pledged promoter holdings is insignificant